THURSDAY, May 5, 2022 (HealthDay News) — Two experimental vaccines show promise in protecting against infection with the “mono” virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports. Tested only in animals so far, the vaccines block two pathwaysContinue Reading

THURSDAY, March 3, 2022 (HealthDay News) — Telemedicine was widely used by Americans with multiple sclerosis (MS) during the pandemic, and many were happy with the results, a new study finds. “The findings suggest that telehealth services were well liked during the pandemic. Because many individuals with MS have physicalContinue Reading

THURSDAY, Feb. 10, 2022 (HealthDay News) — The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis. Now researchers are raising the next logical question — can we stop both MS and mononucleosis by preventing Epstein-Barr infections, which occur in 95% of adults?Continue Reading

WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading

THURSDAY, Dec. 9, 2021 (HealthDay News) — Children at risk for multiple sclerosis (MS) might find some protection from the disease by spending more time in the sun, a small study suggests. Although MS is rare in children and young adults, those with relatives who have the condition have increasedContinue Reading

THURSDAY, Nov. 11, 2021 (HealthDay News) — Multiple sclerosis patients might be able to think more clearly and move more easily if they regularly undergo whole-body vibration training, a new pilot study reports. A small group of MS patients who experienced vibration training showed improvements in decision making, information processing,Continue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading